scholarly article | Q13442814 |
P50 | author | Hsin-Yi Yang | Q92340614 |
P2093 | author name string | Wan-Ting Huang | |
Herng-Sheng Lee | |||
Solomon Chih-Cheng Chen | |||
Yung-Chu Hsu | |||
P2860 | cites work | A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing | Q24673627 |
Irritable Bowel Syndrome | Q61834447 | ||
Drug-Induced Restless Legs Syndrome | Q87885095 | ||
Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis | Q88673222 | ||
Restless legs symptoms in thyroid disorders | Q43499950 | ||
Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study | Q43880983 | ||
Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. | Q44007067 | ||
Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. | Q44120906 | ||
Incidence of restless legs syndrome in two population-based cohort studies in Germany | Q44372039 | ||
The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. | Q45423449 | ||
Cardiovascular risk factors in restless legs syndrome. | Q45969190 | ||
Gender differences in the association between antidepressant use and restless legs syndrome | Q46057248 | ||
Corelease of dopamine and serotonin from striatal dopamine terminals | Q46429998 | ||
Patients with primary restless legs syndrome have higher prevalence of autonomic dysfunction and irritable bowel syndrome | Q47640529 | ||
Association between irritable bowel syndrome and restless legs syndrome in the general population | Q48251452 | ||
Irritable bowel syndrome correlates with increased risk of Parkinson's disease in Taiwan | Q48368095 | ||
Epidemiology of restless legs syndrome in Turkish adults on the western Black Sea coast of Turkey: A door-to-door study in a rural area | Q48402231 | ||
Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. | Q52028290 | ||
Genetics of restless legs syndrome | Q57040687 | ||
Functional bowel disorders | Q29620328 | ||
Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management | Q33753188 | ||
Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! | Q33786003 | ||
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health | Q34273561 | ||
Restless legs syndrome prevalence and impact: REST general population study | Q34426489 | ||
Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis | Q34488657 | ||
Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy | Q34583727 | ||
Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth | Q34629149 | ||
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis | Q34657632 | ||
Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study | Q34745942 | ||
Profile of altered brain iron acquisition in restless legs syndrome | Q34754646 | ||
Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community | Q34756341 | ||
Restless legs syndrome as side effect of second generation antidepressants | Q34777675 | ||
Antidepressants for irritable bowel syndrome | Q35083805 | ||
Epidemiology of restless legs syndrome: a synthesis of the literature. | Q35478498 | ||
Vitamin D Deficiency in Patients with Irritable Bowel Syndrome: Does it Exist? | Q35547840 | ||
Prevalence of restless legs syndrome in patients with irritable bowel syndrome | Q35555727 | ||
Antidepressant medication use and restless legs syndrome in patients presenting with insomnia | Q36220871 | ||
Risk of Restless Legs Syndrome Following Tension-Type Headache: A Nationwide Population-Based Cohort Study | Q36299351 | ||
Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndrome | Q36309834 | ||
Association between irritable bowel syndrome and restless legs syndrome: a comparative study with control group | Q36341718 | ||
Increased Risk of Restless Legs Syndrome in Patients With Migraine: A Nationwide Population-Based Cohort Study | Q36566888 | ||
Genetic aspects of restless legs syndrome | Q36636022 | ||
Restless legs syndrome associated with major diseases: A systematic review and new concept | Q36782910 | ||
Association between the neutrophil-to-lymphocyte ratio, a new marker of systemic inflammation, and restless legs syndrome. | Q37264054 | ||
Sex differences in the psychopharmacological treatment of depression | Q37618539 | ||
Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms | Q37976945 | ||
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis | Q37994513 | ||
Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade | Q38118478 | ||
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis | Q38202523 | ||
The influence of antidepressants on restless legs syndrome and periodic limb movements: A systematic review. | Q38617556 | ||
British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). | Q38858071 | ||
Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome | Q39150062 | ||
Does frequency of restless legs syndrome and poor sleep quality increase with age in irritable bowel syndrome? | Q40583195 | ||
Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article | Q41392745 | ||
Antibiotic therapy may improve idiopathic restless legs syndrome: prospective, open-label pilot study of rifaximin, a nonsystemic antibiotic | Q43204677 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P921 | main subject | irritable bowel syndrome | Q838966 |
restless legs syndrome | Q916280 | ||
population-based cohort study | Q108562148 | ||
P304 | page(s) | e0220641 | |
P577 | publication date | 2019-08-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study | |
P478 | volume | 14 |
Search more.